Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
Shopping Cart: ( empty )
You are here: Home > Journals > SH > SH09100
RESEARCH ARTICLE
Contents Vol 7(1)

Is screening asymptomatic men who have sex with men for urethral gonorrhoea worthwhile?

Nathan Ryder A B C , Ian G. Lockart B and Chris Bourne A B
+ Author Affiliations
- Author Affiliations

A Sydney Sexual Health Centre, Sydney Hospital, GPO Box 1614, NSW 2001, Australia.

B School of Public Health and Community Medicine, University of New South Wales, Randwick, NSW 2031, Australia.

C Corresponding author. Email: nathan.ryder@sesiahs.health.nsw.gov.au

Sexual Health 7(1) 90-91 https://doi.org/10.1071/SH09100
Submitted: 14 September 2009  Accepted: 9 December 2009   Published: 15 February 2010

Abstract

We determined the prevalence of symptomatic and asymptomatic urethral gonorrhoea among men who have sex with men (MSM) at our Australian sexual health clinic. Asymptomatic MSM are screened using the Roche Amplicor® PCR, whereas culture is used for symptomatic MSM. We analysed data from all MSM tested for urethral gonorrhoea from March 2006 to July 2008. Among the 4453 asymptomatic MSM, there were two (0.04%) diagnoses of urethral gonorrhoea, compared with 38 (3.13%) among 1213 symptomatic MSM. Despite a high prevalence of symptomatic infection, asymptomatic urethral gonococcal infection was extremely uncommon among MSM seen in our sexual health clinic.

Additional keywords: Australia, epidemiology, male, screening.


References


[1] Bourne C,  Edwards B,  Shaw M,  Gowers A,  Rodgers C,  Ferson M. Sexually transmissible infection testing guidelines for men who have sex with men. Sex Health 2008; 5 189–91.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[2] Centers for Disease Control and Prevention Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep 2006; 55 1–94.


[3] Lewis DA,  Bond M,  Butt KD,  Smith CP,  Shafi MS,  Murphy SM. A one-year survey of gonococcal infection seen in the genitourinary medicine department of a London district general hospital. Int J STD AIDS 1999; 10 588–94.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[4] Jin F,  Prestage G,  Mao L,  Kippax SC,  Pell CM,  Donovan B, et al. Incidence and risk factors for urethral and anal gonorrhoea and chlamydia in a cohort of HIV-negative homosexual men: the health in men study. Sex Transm Infect 2007; 83 113–9.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[5] Gaydos CA,  Kent CK,  Reitmeijer CA,  Willard NJ,  Marrazzo JM,  Chapin JB, et al. Prevalence of Neisseria gonorrhoeae among men screened for Chlamydia trachomatis in four United States cities, 1999–2003. Sex Transm Dis 2006; 33 314–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |

[6] Benn PD,  Rooney G,  Carder C,  Brown M,  Stevenson S,  Copas A, et al. Chlamydia trachomatis and Neisseria gonorrhoeae infection and the sexual behaviour of men who have sex with men. Sex Transm Infect 2007; 83 106–12.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[7] Kent CK,  Chaw JK,  Wong W,  Liska S,  Gibson S,  Hubbard G, et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California. Clin Infect Dis 2003; 2005 67–74.


[8] Whiley DM,  Tapsall JW,  Sloots TP. Nucleic acid amplification testing for Neiserria gonorrhoeae: an ongoing challenge. JMD 2006; 8 3–15.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |

[9] Zablotska IB,  Imrie J,  Bourne C,  Grulich AE,  Frankland A,  Prestage G. Improvements in sexual health testing among gay men in Sydney, Australia, 2003–2007. Int J STD AIDS 2008; 19 758–60.
| Crossref | GoogleScholarGoogle Scholar | CAS | PubMed |